Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells.
about
Novel drugs that target the metabolic reprogramming in renal cell cancerO-GlcNAcylation and the Metabolic Shift in High-Proliferating Cells: All the Evidence Suggests that Sugars Dictate the Flux of Lipid Biogenesis in Tumor ProcessesDistinct cholesterogenic and lipidogenic gene expression patterns in ovarian cancer - a new pool of biomarkersIt's Totally Tubular....Riding The New Wave of Ovarian Cancer Research.Inhibition of fatty acid synthase is protective in pulmonary hypertension.Increased expression of fatty acid synthase and acetyl-CoA carboxylase in the prefrontal cortex and cerebellum in the valproic acid model of autismCrosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis.Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells.Fatty acid synthase inhibits the O-GlcNAcase during oxidative stress.Fatty acid synthase expression and its association with clinico-histopathological features in triple-negative breast cancer.Epistructured catechins, EGCG and EC facilitate apoptosis induction through targeting de novo lipogenesis pathway in HepG2 cells.Hitting two oncogenic machineries in cancer cells: cooperative effects of the multi-kinase inhibitor ponatinib and the BET bromodomain blockers JQ1 or dBET1 on human carcinoma cells.Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism.
P2860
Q26740187-4E4A91F9-B347-47D8-AF2A-5B08C43BDA38Q26770270-A3DEC9F9-3CC1-4C23-B497-0304817CB946Q36430122-5D6E320B-8993-4FA3-AFF4-EE52524E895BQ36436803-0BC71248-4F38-442C-ABDB-CA7C900A161BQ36941262-4157A7FE-A1D6-4352-BCFE-C9C2F21B2B73Q37204659-B42EE339-E3F7-4841-806C-18327C0165C5Q37644800-01D3805C-B385-4010-AC43-680051940471Q37706959-D99BA011-9792-4970-B5CC-1C260B108569Q38715120-45DA668B-5BFE-4135-AA8C-551B422F29FEQ44076458-EC153906-712E-4CE5-B97E-71F68B37C758Q52626638-6687F17E-435B-4756-9141-05861BEF8A03Q55248424-B67A2A69-327E-4470-A1EC-77243D326F9EQ55396904-B23CFFCE-0869-49D5-A96A-7E8EF4270E4F
P2860
Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Fatty acid synthase is a metab ...... ancer and its precursor cells.
@en
type
label
Fatty acid synthase is a metab ...... ancer and its precursor cells.
@en
prefLabel
Fatty acid synthase is a metab ...... ancer and its precursor cells.
@en
P2093
P2860
P50
P356
P1476
Fatty acid synthase is a metab ...... cancer and its precursor cells
@en
P2093
Asha Leisser
Daniel Veigel
Fausto G Hegardt
Gerald Stübiger
Jordi García
Martin Filipits
Michael Wuczkowski
Nelly Auersperg
Reinhard Horvat
Renate Wagner
P2860
P304
P356
10.1002/IJC.29261
P50
P577
2014-11-03T00:00:00Z